three
group
calv
n
per
group
fed
pool
colostrum
supplement
birth
age
brv
seroposit
cow
vaccin
recombin
sall
p
rotavinuslik
particl
vlp
recombin
sall
rotaviru
corelik
particl
clp
inactiv
sall
rotaviru
sall
control
calv
n
per
group
receiv
either
pool
colostrum
unvaccin
brv
field
exposur
seroposit
control
cow
colostrum
iggl
antibodi
titer
ind
brv
pool
colostrum
vlp
clp
sali
control
colostrum
elev
titer
brv
neutral
vn
antibodi
present
vlp
colostrum
sall
colostrum
clp
colostrum
compar
colostrum
j
om
nonvaccin
calv
oral
inocul
virul
inl
brv
day
age
challeng
postinocul
day
pid
calv
monitor
daili
diarrhea
faecal
brv
shed
pid
postchalleng
day
pcd
colostrum
feed
iggl
antibodi
titer
highest
serum
faec
calv
fed
vlp
clp
colostrum
vn
iga
antibodi
highest
calv
fed
vlp
colostrum
brv
inocul
calv
fed
colostrum
vaccin
cow
significantli
fewer
day
brvassoci
diarrhea
brv
shed
control
calv
calv
fed
vlp
colostrum
protect
diarrhea
brv
inocul
two
calv
shed
brk
clp
colostrum
group
one
calf
develop
brvassoci
diarrhea
calv
shed
viru
sall
colostrum
group
three
calv
develop
brvassoci
diarrhea
four
calv
shed
viru
brvassoci
diarrhea
shed
occur
control
calv
activ
igm
antibodi
respons
occur
faec
andor
serum
calv
brv
inocul
howev
highest
activ
antibodi
respons
iggl
serum
igm
iggl
faec
brv
inocul
calv
fed
control
colostrum
associ
clinic
diarrhea
calv
challeng
pid
brvassoci
diarrhea
shed
short
durat
absent
group
result
demonstr
efjicaci
colostrum
vlp
vaccin
cow
provid
heterolog
passiv
protect
brv
diarrhea
shed
calv
comparison
calv
fed
clp
sall
colostrum
partial
protect
brv
diarrhea
shed
elsevi
scienc
ltd
right
reserv
passiv
immun
bovin
rotaviru
fm
fernandez
et
al
bovin
rotaviru
brv
import
caus
diarrhea
calv
week
age
protect
brv
diarrhea
infect
calv
nurs
period
correl
high
level
neutral
antibodi
calf
intestin
mainli
associ
iggi
passiv
acquir
via
colostrum
although
cow
seroposit
brv
due
field
exposur
unvaccin
cow
antibodi
titer
milk
declin
unprotect
level
parturit
second
determin
brv
antibodi
isotyp
titer
serum
faec
calv
also
examin
calv
passiv
protect
initi
inocul
brv
immun
subsequ
brv
challeng
exposur
day
later
passiv
protect
studi
whey
obtain
colostrum
pool
describ
previous
use
assay
determin
viru
neutral
isotyp
elisa
antibodi
titer
ind
brv
unsuckl
newborn
colostrumdepriv
cd
male
holstein
calv
procur
maintain
describ
previous
five
calv
assign
four
colostrum
feed
group
vlp
clp
inactiv
sal
control
colostrum
fed
supplement
pool
colostrum
ml
colostrum
cow
milk
infant
formula
respect
colostrum
pool
twice
day
birth
day
age
five
control
calv
fed
colostrum
maintain
infant
formula
calv
hour
age
oral
inocul
suspens
ml
ind
brv
titer
ffu
ml
ml
phosphatebuff
salin
solut
pb
ph
prepar
intestin
content
infect
gnotobiot
cal
ind
brv
titer
ml
oral
challeng
day
later
prepar
administ
similar
manner
daili
record
birth
pid
pcd
maintain
clinic
sign
observ
stool
color
consist
faecal
score
normal
liquid
score
indic
diarrhea
faecal
sampl
collect
daili
birth
pid
pcd
serum
sampl
collect
initi
colostrum
feed
within
h
birth
inocul
h
age
weekli
postinocul
day
pid
detect
coproantibodi
faecal
sampl
suspend
pb
dilut
centrifug
min
soog
filter
lrn
syring
filter
serum
sampl
inactiv
min
store
frozen
subsequ
test
detect
rotaviru
shed
examin
immunoelectron
faecal
sampl
microscopi
cell
passiv
immun
bovin
rotaviru
fm
fernandez
et
al
cultur
immunofluoresc
ccif
antigen
captur
elisaj
previous
describ
sampl
consid
rotaviru
posit
posit
one
three
assay
rotaviru
posit
sampl
also
evalu
polyacrylamid
gel
electrophoresi
page
confirm
dsrna
electropherotyp
challeng
strain
brv
ind
titer
day
brv
shed
day
brvassoci
diarrhea
cumul
faecal
score
also
analys
diarrhea
consid
brvassoci
rotaviru
antigen
viru
detect
time
period
diarrhea
cumul
faecal
score
calcul
pid
inclus
time
interv
use
repres
protect
effect
oral
colostr
supplement
fed
includ
pid
iggi
iga
igm
antibodi
respons
ind
brv
p
analys
serum
weekli
faccal
specimen
use
indirect
isotypcspecif
elisa
previous
de
jcribe
briefli
polystyren
microtit
plate
coat
lg
ml
bicarbon
buffer
ph
hyperimmun
antiserum
brv
produc
gnotobiot
pig
captur
antibodi
plate
store
day
plate
wash
use
pb
contain
tween
pbst
prior
addit
standard
volum
ml
well
reagent
dilut
pbst
follow
h
sequenti
incub
reagent
humid
co
atmospher
semipurifi
ind
brv
infect
cell
cultur
ur
mockinfect
cell
cultur
control
fluid
ad
well
follow
addit
test
serum
faecal
sampl
serial
fourfold
dilut
start
antigenco
control
mock
antigen
well
secondari
antibodi
consist
mab
ascit
bovin
iggi
igm
loooo
iga
ad
separ
plate
follow
indic
antibodi
goat
antimous
igg
hl
f
ab
conjug
alkalin
phosphatas
substrat
pnitrophenyl
phosphat
diethanolamin
buffer
ph
absorb
read
elisa
reader
nm
elisa
antibodi
titer
express
reciproc
highest
sampl
dilut
absorb
sd
background
control
sampl
mock
antigen
well
analys
varianc
anova
perform
detect
signific
differ
among
experiment
group
differ
note
least
signific
differ
lsd
test
appli
signitic
level
p
use
throughout
elisa
isotyp
antibodi
titer
colostrum
pool
ind
brv
arc
summar
tabl
vlp
colostrum
pool
highest
vn
antibodi
titer
higher
control
colostrum
pool
follow
inactiv
sall
colostrum
pool
higher
control
colostrum
pool
vn
antibodi
titer
clp
control
colostrum
pool
similar
elisa
iggl
antibodi
titer
brv
highest
vlp
clp
colostrum
pool
higher
sall
control
colostrum
pool
respect
predomin
antibodi
isotyp
colostrum
iga
antibodi
titer
vlp
colostrum
pool
higher
clp
inactiv
sal
colostrum
pool
looofold
higher
control
colostrum
pool
higher
low
igm
antibodi
titer
detect
vaccin
colostrum
pool
compar
control
colostrum
low
antibodi
titer
brv
detect
vlp
colostrum
pool
colostr
whey
colostrum
pool
process
along
w
lth
calf
sera
faec
test
plaqu
reduct
viru
neutral
test
detect
neutral
antibodi
titer
ind
antibodi
titer
express
reciproc
highest
sampl
dilut
result
reduct
n
number
cow
group
entir
first
milk
colostrum
rang
cow
collect
pool
mix
thoroughli
geometr
mean
antibodi
titer
sampl
cow
contribut
pool
publish
previous
passiv
immun
bovin
rotaviru
fm
fernandez
et
al
significantli
fewer
day
brvassoci
diarrhea
calv
receiv
control
colostrum
colostrum
tahlc
addit
diarrhea
significantli
less
sever
measur
cumul
faecal
score
calv
receiv
vlp
clp
colostr
supplement
calv
control
group
although
differ
among
three
vaccin
group
statist
signific
calv
vlp
colostrum
group
lowest
mean
day
viru
shed
lowest
mean
cumul
faecal
score
none
vlp
colostrum
calv
experienc
brvassoci
diarrhea
howev
one
calf
develop
brvassoci
diarrhea
pid
day
day
colostrum
supplement
end
data
shown
pid
onset
pid
brv
diarrhea
shed
calf
shown
tabl
antibodi
titer
serum
faec
calv
differ
colostrum
feed
group
arc
summar
tghlr
figur
initi
sampl
h
birth
calv
neg
rotaviru
antibodi
titer
serum
faec
data
shown
serum
faecal
antibodi
titer
calv
fed
colostrum
vaccin
cow
increas
first
feed
peak
faecal
antibodi
titer
attain
calv
day
age
pid
possibl
due
delay
passag
gastrointestin
content
individu
tabl
serum
faecal
iggl
antibodi
significantli
higher
calv
fed
vlp
clp
colostrum
calv
control
group
titer
decreas
cessat
colostrum
feed
figur
titer
serum
faecal
iga
antibodi
significantli
higher
calv
receiv
vlp
colostrum
calv
four
group
viru
neutral
antibodi
titer
low
gmt
faec
calv
group
within
day
brv
inocul
except
faec
calv
fed
vlp
colostrum
gmt
data
shown
correspond
highest
vn
antibodi
titer
detect
pool
vlp
colostrum
tabl
attempt
clarifi
whether
calv
passiv
protect
inocul
brv
develop
immun
subsequ
challeng
challeng
pid
signific
differ
number
day
brv
shed
day
brvassoci
diarrhea
among
vaccin
colostrum
control
group
howev
signific
differ
evid
iggl
antibodi
gmt
serum
faec
time
challeng
pid
highest
gmt
control
group
compris
calv
recov
brv
shed
diarrhea
inocul
tahk
calv
receiv
control
colostrum
colostrum
peak
igm
antibodi
respons
brv
detect
serum
faecal
specimen
pid
preced
iggl
iga
antibodi
respons
occur
pid
f
re
antibodi
titer
brv
detect
serum
challeng
pcd
iga
antibodi
titer
brv
increas
serum
faec
control
colostrum
fed
calv
brv
challeng
highest
activ
antibodi
respons
igm
iggl
serum
igm
iggl
iga
faec
occur
two
group
figur
vlp
colostrum
fed
calv
low
igm
antibodi
respons
brv
detect
serum
faec
inocul
increas
igm
iggl
antibodi
detect
faec
challeng
figur
clp
colostrum
fed
calv
transient
igm
antibodi
respons
detect
faec
brv
inocul
increas
iggl
iga
antibodi
respons
detect
brv
inocul
unsuckl
newborn
calv
fed
colostrum
pool
twice
daili
birth
day
age
indic
group
oral
inocul
ind
brv
hour
age
oral
challeng
ind
brv
day
age
day
diarrhea
pid
pid
analys
repres
protect
effect
oral
colostr
supplement
fed
includ
pid
stool
consist
score
daili
normal
liquid
cumul
score
pid
pid
calcul
measur
sever
diarrhea
six
calv
experienc
mild
diarrhea
absenc
rotaviru
shed
possibl
relat
diet
unidentifi
infect
consid
rotaviru
diarrhea
purpos
calcul
two
calv
clp
colostrum
group
two
sal
colostrum
group
two
colostrum
group
group
column
differ
letter
superscript
differ
significantli
group
column
letter
superscript
differ
significantli
group
column
lack
letter
superscript
differ
significantli
tion
challeng
figt
inactiv
sai
colostrum
fed
calv
peak
igm
respons
detect
serum
faec
inocul
preced
peak
iga
antibodi
respons
faec
f
w
iggl
antibodi
titer
serum
faec
remain
constant
decreas
challeng
previou
studi
demonstr
calv
fed
colostrum
cow
immun
experiment
rotaviru
vaccin
protect
rotaviru
infect
diarrheaj
x
protect
calv
correl
presenc
high
level
neutral
rotaviru
antibodi
colostrum
mainli
associ
variabl
result
report
field
trial
use
inactiv
live
serum
sampl
collect
pid
antibodi
titer
fecal
sampl
repres
peak
pid
fecal
antibodi
titer
show
delay
increas
within
time
calv
possibl
due
delay
passag
intestin
content
bunsuckl
newborn
calv
fed
colostrum
pool
twice
daili
birth
day
age
indic
group
oral
inocul
ind
brv
hour
age
postinocul
day
onset
durat
brv
shed
diarrhea
note
sum
daili
score
fecal
consist
pid
inclus
calf
shed
brv
termin
colostrum
feed
begin
pid
continu
day
calv
antibodi
titer
oi
design
calcul
gmt
nd
done
group
column
differ
superscript
differ
significantli
passiv
immun
bovin
rotaviru
fm
fernandez
et
al
construct
induc
antibodi
provid
partial
passiv
immun
mice
experiment
colostrum
pool
vlp
clp
inactiv
sai
vaccin
cow
control
colostrum
pool
highest
iggi
titer
detect
vlp
clp
colostrum
pool
contrast
vn
antibodi
titer
clp
colostrum
pool
similar
control
colostrum
confirm
inabl
protein
induc
vn
antibodi
even
field
expos
rotaviru
seroposit
cow
other
report
similar
failur
protein
induc
vn
antibodi
experiment
anim
although
work
use
mice
demonstr
sal
rotaviru
studi
indic
posit
associ
antibodi
titer
colostrum
antibodi
peptid
construct
coupl
assembl
consist
induc
format
neutral
antibodi
afford
passiv
protect
newborn
mice
howev
best
passiv
protect
induc
moreov
administr
purifi
baculovirusexpress
pcptide
alon
fail
increas
neutral
antibodi
titer
cow
mice
titer
serum
facc
calv
colostrum
hour
age
stool
collect
time
feed
studi
calf
serum
iggl
antibodi
meconiumlik
calv
suggest
ingest
titer
brv
tirn
inocul
reflect
colostrum
supplement
yet
pass
length
titer
colostrum
fed
antibodi
titer
intestin
tract
antibodi
titer
faec
calv
receiv
vlp
colostrum
clp
colostrum
calv
peak
pid
unclear
whether
similar
significantli
higher
titer
antibodi
transud
serum
calv
receiv
inactiv
sai
control
colosof
calf
intestin
previous
trum
calv
fed
inactiv
sai
colostrum
signipropos
studi
passiv
immun
brv
ticantli
higher
titer
han
calv
receiv
control
besser
et
peak
faecal
iggl
antibodi
titer
pid
colostrum
colostrum
faecal
antibodi
titer
significantli
higher
calv
receiv
vlp
highli
variabl
within
group
time
inocul
clp
colostrum
antibodi
titer
two
group
calv
three
group
calv
receiv
colostrum
supplement
vaccin
cow
significantli
fewer
day
brv
diarrhea
shed
follow
inocul
calv
control
group
report
previous
high
vn
titer
necessari
complet
protect
associ
exist
vn
antibodi
titer
protect
calv
investig
studi
mice
piglet
report
correl
faecal
iga
antibodi
intestin
iga
antibodi
secret
cell
respect
protect
rotaviru
challeng
calv
present
studi
receiv
vlp
colostrum
high
titer
iggl
antibodi
serum
facc
high
titer
iga
antibodi
vn
antibodi
faec
group
calv
lowest
mean
day
brv
shed
brv
diarrhea
colostrum
supplement
fed
unclear
whether
vn
antibodi
iga
antibodi
instrument
protect
elev
group
calv
receiv
clp
colostrum
similar
titer
iggl
antibodi
serum
faec
pid
calv
vlp
group
low
titer
iga
vn
antibodi
although
five
calv
clp
group
shed
brv
one
calf
experienc
diarrhea
receiv
colostrum
supplement
indic
least
partial
protect
studi
mice
suggest
high
titer
nonneutr
antibodi
major
structur
protein
contribut
partial
passiv
protect
rotaviru
diarrhea
calv
passivelyderiv
iggl
transfer
serum
gastrointestin
tract
birth
serumderiv
iggl
antibodi
may
contribut
passiv
intestin
immun
brv
unclear
whether
mechan
passiv
protect
afford
nonneutr
iggl
antibodi
calv
cell
durin
g
dimer
iga
transport
whether
receptor
iggl
transport
across
intestin
epitheli
cell
exist
calv
compar
polymer
ig
receptor
dimer
iga
transport
unknown
although
fcspecif
receptor
iggl
exist
alveolar
epitheli
cell
bovin
mammari
gland
contribut
select
transport
iggl
serum
bovin
mammari
secret
presenc
compar
fc
receptor
iggi
intestin
epitheli
cell
calv
investig
calv
receiv
colostrum
cow
vaccin
inactiv
sai
vaccin
shed
viru
compar
length
time
calv
clp
group
highest
mean
day
rotaviru
diarrhea
highest
cumul
faecal
score
calv
three
vaccin
group
although
moder
titer
iggl
antibodi
present
serum
faec
calv
pid
iga
vn
antibodi
titer
low
higher
vn
antibodi
titer
vlp
colostrum
calv
probabl
relat
consist
high
antigen
concentr
vlp
vaccin
present
immunogen
form
associ
intact
triplelay
particl
lower
concentr
inactiv
sall
rotaviru
vaccin
may
major
factor
limit
effect
type
convent
vaccin
process
inactiv
may
alter
structur
antigen
nativ
viru
particl
decreas
immunlogen
present
studi
calv
receiv
colostrum
control
colostrum
develop
activ
immun
respons
rotaviru
inocul
igm
antibodi
present
serum
faec
pid
iga
iggl
antibodi
evid
faec
pid
iggl
antibodi
appear
serum
time
activ
immun
respons
calv
receiv
colostrum
vaccin
cow
lower
magnitud
develop
later
present
consist
mainli
igm
find
consist
suppress
activ
immun
respons
matern
antibodi
surprisingli
although
control
calv
strong
serolog
evid
activ
immun
respons
brv
time
challeng
three
group
littl
brv
diarrhea
shed
group
possibl
immun
prime
occur
presenc
matern
antibodi
deserv
investig
altern
explan
would
suffici
residu
passiv
antibodi
resecret
serum
intestin
present
pid
provid
observ
level
protect
brv
challeng
exposur
result
support
abil
heterotyp
sall
vlp
vaccin
sall
clp
inactiv
vaccin
p
induc
complet
partial
passiv
protect
calv
serotyp
unrel
brv
strain
p
vlp
vaccin
possess
potenti
advantag
exist
brv
vaccin
includ
safeti
due
inabl
replic
lack
adventiti
agent
potenti
present
live
vaccin
consist
express
vlp
stabl
immunogen
form
addit
studi
need
analys
role
mechan
passiv
immun
associ
clp
vaccin
induc
nonneutr
antibodi
major
structur
protein
nevertheless
mediat
least
partial
passiv
protect
calv
